Background: Malignant Pleural Effusion (MPE) is a condition that mostly presents with dyspnea. There are some ways to distinguish it from NonMalignant Pleural Effusion (NMPE).The aim of this study was to compare serum and pleural D-dimer levels between MPE and NMPE patients. Materials and Methods: Patients diagnosed with Pleural Effusion (PE) were selected to participate in this study. They were allocated in 2 groups of MPE and NMPE according to the etiology. Serum and pleural fluid D-dimer level were measured and statistically analyzed between two groups. Results: 32 MPE patients and 32 NMPE patients participated in this study. The mean age was 61.3 ± 12 years and M/F ratio was 35/29. The mean pleural and serum D-dimer levels were 3472± 1312 ng/dl and 3259±1220 ng/dl in patients with MPE, and 3425 ± 32.5ng/dl and 2425 ± 1311ng/dl in patients with NMPE, respectively. The serum D-dimer levels were not statistically different between 2 groups; while the pleural D-dimer levels were higher in MPE group in comparison with NMP patients (P<0.05).
INTRODUCTION
Pleural Effusion (PE) is defined as collection of fluid in pleural space and classified into two categories of exudative and transudative PE (1) . PE is the result of a wide range of medical conditions including infection, malignancy, trauma, collagen vascular disease, etc. (2, 3) .
Malignancy is one of the main causes of exudative PE, which is called Malignant Pleural Effusion (MPE) (4) . The most common symptom of PE is dyspnea, but there are many signs and symptoms that lead to this diagnosis. The diagnosis of PE is almost based on physical examination but paraclinical tests like CXR can help to confirm it (5) .
Also laboratory tests such as pleural LDH and protein and comparison with simultaneous serum level of these markers can distinguish the causes of PE (6) . Treatment of PE depends on managing the underlying cause, hence it is important to diagnose it as soon as possible (5, 7, 8) Recent researches suggested that pleural D-dimer levels can be a helpful marker to propose malignancy as the cause of PE (9) (10) (11) . D-dimer is a peptide that results from fibrin cleavage during homeostasis. Its serum levels increase in many physiological and pathological states such as inflammation and hypercoagulable state (12, 13) . It has been shown that the hypercoagulable state in MPE fluid prevents fibrin aggregation and leads to increase production of D-dimer (9) . The aim of this study was to compare serum and pleural D-dimer levels between malignant and nonmalignant PE patients.
MATERIALS AND METHODS
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RESULTS
In this survey, 64 patients with PE were separated into two groups; 32 patients in malignant group and 32 patients in non-malignant group. Table 1 and pleural D-dimer levels in participants according to their underlying disease. Table 2 showed that there were statistically significant differences between malignant and non-malignant effusions according to the pleural levels of D-dimer (P=0.01). However, there were no statistically significant differences between malignant and non-malignant effusions in comparison of serum levels of D-dimer. number may affect the application of our findings.
Analysis of data with
Secondly, our study is an observational study; we did not do further work on the detail mechanism on how malignancy affects local fibrinolysis system. Further studies at a large scale and aiming to investigate the detailed mechanism should be carried out to confirm our findings. 
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